Author

Iglika G. Ivanova

Massachusetts General HospitalORCID 0000-0001-7417-2348Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Andrew Michael FreyiD· 1 shared Andrew PauliD· 1 shared Christopher J. LordiD· 1 shared Christopher P. A. T. LawsoniD· 1 shared David R. AdamsiD· 1 shared Emily StephensoniD· 1 shared Éva ÁdámiD· 1 shared Gary ReynoldsiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andrew Michael FreyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintJan 31, 2025

Targeting non-canonical NF-κB signalling in CYLD cutaneous syndrome by selective inhibition of IκB kinase alpha.

Kirsty Hodgson, Joseph Inns, Gary Reynolds…·Neil Rajan

This study identifies non-canonical NF-κB signalling as a therapeutic target in CYLD cutaneous syndrome and shows that IKK inhibition reduces tumor viability in patient-derived models.

3 citations

humanproteomics

𝕏 PostBluesky